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Previous meta-analyses of intervention studies have come to different conclusions about 20 
effects of consumption of low-calorie sweeteners (LCS) on body weight. The present review 21 
included 60 articles reporting 88 parallel-groups and cross-over studies ≥ 1 week in duration 22 
that reported either body weight (BW), BMI and/or energy intake (EI) outcomes. Studies 23 
were analysed according to whether they compared (1) LCS with sugar, (2) LCS with water or 24 
nothing, or (3) LCS capsules with placebo capsules. Results showed an effect in favour of LCS 25 
vs sugar for BW (29 parallel-groups studies, 2267 participants: BW change, -1.06 kg, 26 
95%CI -1.50 to -0.62, I2 = 51%), BMI and EI. Effect on BW change increased with ‘dose’ of 27 
sugar replaced by LCS, whereas there were no differences in study outcome as a function of 28 
duration of the intervention or participant blinding. Overall, results showed no difference in 29 
effects of LCS vs water/nothing for BW (11 parallel-groups studies, 1068 participants: BW 30 
change, 0.10 kg, 95%CI -0.87 to 1.07, I2 = 82%), BMI and EI; and inconsistent effects for LCS 31 
consumed in capsules (BW change: -0.28 kg, 95%CI -0.80 to 0.25, I2 = 0%; BMI change: 0.20 32 
kg/m2, 95%CI 0.04 to 0.36, I2 = 0%). Occurrence of adverse events was not affected by the 33 
consumption of LCS. The studies available did not permit robust analysis of effects by LCS 34 
type. In summary, outcomes were not clearly affected when the treatments differed in 35 
sweetness, nor when LCS were consumed in capsules without tasting; however, when 36 
treatments differed in energy value (LCS vs sugar), there were consistent effects in favour of 37 
LCS. The evidence from human intervention studies supports the use of LCS in weight 38 
management, constrained primarily by the amount of added sugar that LCS can displace in 39 





Low-calorie sweeteners (LCS), for example acesulfame-K, aspartame, cyclamate, saccharin, 42 
steviol glycosides and sucralose, provide the pleasure of sweetness without calories. As 43 
such, use of LCS can be expected to contribute to the goals of international 44 
recommendations to reduce intake of sugar and to reduce the prevalence of overweight 45 
and obesity.1 The role of LCS in healthy weight management, however, has been disputed 46 
on both empirical and theoretical grounds. This includes evidence from observational 47 
studiese.g.2,3, the proposal that exposure to sweetness without calories disrupts appetite 48 
control3-5 and a concern that exposure to sweetness increases preference for sweet, energy-49 
containing items in the diet.6,7 In relation to the latter claims, there is little compelling 50 
support for either the ‘sweet taste confusion’ or ‘sweet tooth’ hypotheses.8,9 Furthermore, 51 
observational studies, including prospective cohort studies, are subject to confounding and 52 
reverse causation10, which leaves intervention studies, that is, randomised controlled trials 53 
(RCTs), as the primary source of evidence concerning the effects of LCS on body weight (BW) 54 
and body mass index (BMI). 55 
A variety of RCTs investigating the effects of sustained (long-term) exposure to LCS 56 
on BW have been carried out. Two systematic reviews that included meta-analyses found 57 
combined evidence in favour of a beneficial effect (relatively lower BW) of LCS 58 
consumption10,11, with our earlier review concluding that “Overall, the balance of evidence 59 
indicates that use of low-energy sweeteners in place of sugar, in children and adults, leads 60 
to reduced energy intake and body weight, and possibly also when compared with water” (p 61 
38110). In contrast, two subsequent meta-analytic reviews12,13 concluded that there was no 62 
clear evidence of a difference between the effects on BW of consumption of LCS vs control. 63 
In planning the present review, we set out to resolve these different conclusions in the light 64 
of the comparisons made between LCS and different controls and the recent publication of 65 
further relevant RCTs.  66 
Specifically, we framed our literature search strategies and data analyses according 67 
to three questions concerning potential effects of LCS on BW14: the effects of (1) LCS 68 
compared with sugar (i.e., when there is a difference in energy content of the target 69 
beverages and/or foods consumed, while taste is controlled); (2) LCS compared with water 70 
or nothing given to the comparator group (i.e., where there is no meaningful difference in 71 
energy content between treatments, while there is a difference in sweet taste); and (3) LCS 72 
in capsules vs placebo capsules (i.e., where there is no meaningful difference in energy 73 
content between treatments, nor a difference in taste). The first of these questions bears on 74 
a primary intended use of LCS, namely the effects of reduction in sugar and energy content 75 
of beverages and foods. The second question concerns the effects of exposure to sweet 76 
taste, which might be to increase or help satisfy desire for sweetness, or to have no 77 
effect.8,9,15 The third question concerns the possibility that LCS have effects on appetite, or 78 
even energy expenditure, via post-ingestive actions in the gut or post-absorptively.14,16 We 79 
included studies that exposed participants to LCS and one or more of the relevant 80 
comparators for ≥ 1 week and measured BW, BMI and/or daily EI. We included EI as an 81 
outcome, as effects of LCS on BW and BMI can be expected to occur primarily via effects on 82 




consumption of LCS for one week, assessment of EI during part or all of that period will 84 
likely predict the effect on BW of longer-term consumption of LCS.  85 
 86 
METHODS 87 
The protocol for this systematic review and meta-analyses was registered in the 88 
international prospective register of systematic reviews (PROSPERO registration number: 89 
CRD42019135483). Differences between this protocol and our final methods are reported 90 
on Supplementary Information (SI) p 2. The review was conducted and reported in 91 
accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 92 
(PRISMA) statement guidelines.18 All research, analysis and writing for this review was 93 
undertaken solely by the two named authors. 94 
 95 
Definitions 96 
For the purposes of this review, we defined LCS as sweeteners and blends of sweeteners 97 
that, by virtue of their highly intense sweet taste (high potency), contribute sweetness but 98 
zero or negligible energy to a food or beverage product. This group of chemically diverse, 99 
sweet-tasting compounds includes aspartame which has an energy value of 17 kJ/g, but for 100 
humans is 180-200 times sweeter than sucrose. So, for example, where aspartame replaces 101 
50 g of sugar in a beverage it contributes 4 kJ vs 837 kJ. Essentially, therefore, aspartame 102 
like truly zero-calorie intense sweeteners such as acesulfame-K, saccharin and sucralose, 103 
provides ‘sweetness without calories’.19 We defined sugar as monosaccharides and 104 
disaccharides, typically sucrose, fructose, glucose, glucose syrup and high-fructose syrup.20 105 
Both this definition of sugar20, and the definition of LCS, excludes sugar alcohols (polyols) 106 
such as erythritol.  107 
Throughout this review we use the term ‘study’ to refer to a comparison between 108 
LCS and either (1) sugar, (2) water/nothing, or (3) placebo. In some instances, the research 109 
compared participants randomised to LCS, sugar or watere.g.21,22 thereby contributing two 110 
studies, namely LCS vs sugar, and LCS vs water. In another example the research compared 111 
participants randomised to saccharin, aspartame, rebaudioside A, sucralose and sucrose23, 112 
contributing four studies: each LCS vs sucrose. Overall, therefore, the number of studies 113 
exceeds the number of articles, even though for some studies information for the same 114 
study was taken from more than one article.e.g.24,25  115 
 116 
Search strategy 117 
Four academic databases: MEDLINE, EMBASE and Web of Science and the Cochrane Library 118 
were searched using two separate searches which included: 1) a ‘sweetener’ term combined 119 
with a ‘body weight’ term or an ‘energy intake’ term; or 2) a ‘sweetener’ term combined 120 
with a ‘capsule’ or ‘capsules’ term. Specific search terms are reported on SI pp 3-4. Terms 121 
were searched for in ‘title’ and ‘abstract’ fields, for all years of records. Searches were 122 
limited to include studies in humans where possible. Only the published literature, including 123 
abstracts and trial registrations, was considered. We also searched the reference lists of 124 
included articles and searched the issues of journals that contained identified articles. Our 125 
intention was to include as much of the relevant published literature as possible. 126 
 127 
Study Inclusion  128 
Studies were considered suitable for inclusion in the review if they: included exposure to 129 




and used a parallel-groups or a within-subjects design. Studies were included regardless of 131 
mode of LCS delivery, including the use of instructions to consume LCS, to continue 132 
consuming foods and/or beverages containing LCS, or to consume capsules containing LCS. 133 
To allow inclusion of as many studies as possible where effects on BW and/or EI may be 134 
found, exposure to LCS was required for ≥ 1 week, where the intervention period was 135 
considered to be the total period for which LCS exposure was manipulated or requested. 136 
Suitable comparators were exposure to, or instructions to consume or to continue to 137 
consume equivalent foods and/or beverages without LCS (foods and/or beverages 138 
containing sugar, or equivalent unsweetened foods and/or beverages (e.g., water)), to 139 
consume no additional foods or beverages (e.g., usual diet, wait-list control), or to consume 140 
placebo (presumably inert) capsules. Studies in which LCS exposure was part of an 141 
intervention strategy that included other elements (e.g., other dietary advice) were included 142 
provided those other elements were also present in the comparator group.e.g.24,26,27 We 143 
included five studies from three articles where information or misinformation was provided 144 
to participants.28-30 For these studies we compared groups provided with the same 145 
information on the basis that only sweetener (LCS vs sugar) and not information differed 146 
between groups (we considered these studies to be blinded). We did not include studies in 147 
which the LCS treatment was confounded with another treatment (i.e., which was not 148 
controlled for in the comparator group).e.g.31-33  149 
Studies were included if they included a measure of BW and/or BMI before and at 150 
the end of the intervention, a measure of EI during and/or at the end of the intervention, 151 
and/or a change in BW and/or BMI over the intervention period. Our primary outcomes 152 
were change in BW/BMI from baseline to the end of the intervention (longest period 153 
reported) and adverse events during the intervention. Secondary outcomes were BW/BMI 154 
at the end of the intervention, EI during or at the end of the intervention and, where 155 
available, measures of anthropometry, such as waist circumference. We only considered BW 156 
and BMI where these outcomes were measured objectively (self-reported BW or BMI 157 
measures were not accepted), and for EI where it was measured using diet diaries or dietary 158 
recall. The methods for EI measurement are detailed in the SI Details of Included Studies 159 
file, column K. Measures of anthropometry were only investigated in studies that also 160 
assessed BW or BMI. Studies were included regardless of gender, age, weight status or 161 
health status of the population studied, and regardless of study setting, context or location.   162 
 163 
Data extraction 164 
Searches were undertaken by PJR. All search results were first screened for study inclusion 165 
via titles and abstracts independently by both authors, and all potentially relevant articles 166 
were obtained. All these articles were screened independently by both authors. Articles 167 
were only discarded if they were clearly considered unsuitable for inclusion in the review by 168 
both authors. Discordances were resolved by discussion. Data on methodological aspects of 169 
each study, all relevant available outcomes and risk of bias (ROB) were subsequently 170 
extracted, independently by both authors, for each relevant study, using a data extraction 171 
form developed specifically for the work. Data were collated by study rather than by article, 172 
to guard against overinclusion of some original studies that contributed to several reports. 173 




review were required, we attempted to contact authors requesting the relevant 175 
information. Study authors were also contacted if published data were unclear in relation to 176 
our research question, or were partial. Studies were subsequently included or excluded 177 
based on this information. The instances where data were obtained and included in the 178 
present analyses are noted in the SI Details of Included Studies file, column AE.  179 
 180 
Risk of bias assessment 181 
ROB was assessed using the six domains recommended by the Cochrane collaboration34: 182 
randomization; allocation concealment; blinding of participants and researchers; use of ITT 183 
analysis; drop out; incomplete outcome reporting; and other. For each domain, ROB was 184 
judged independently by both authors, as ‘low’, ‘high’ or ‘unclear’ (or, additionally for 185 
blinding only, ‘not possible’), based on published information. Criteria for ROB judgements 186 
are given in SI p 5. Discordances were discussed and resolved, and judgements tabulated. 187 
Funding source (partly or solely funded by industry vs no industry funding) was recorded but 188 
did not contribute to judgments of ROB. 189 
 190 
Data synthesis and analysis 191 
All studies were considered per research question and per study design (parallel-groups and 192 
cross-over designs). Studies are ordered in all results tables and figures below by 193 
intervention length (longest first) and then date of publication (most recent first). BW, BMI, 194 
EI and adverse events data were subsequently combined using meta-analysis. Analyses were 195 
conducted separately on studies using parallel-groups and cross-over designs to allow an 196 
adjustment for the reduced within-study variance in studies using a cross-over design. 197 
Analyses were conducted separately for change in BW (ΔBW) and change in BMI (ΔBMI) 198 
over the longest period of the intervention, BW and BMI at the end of the intervention 199 
(BWend and BMIend, respectively). Because BW is a cumulative effect of EI and energy 200 
expenditure, we analysed EI during the intervention averaged across all available time 201 
points, or solely at the end of the intervention if those were the only data available. Adverse 202 
events occurring during the intervention (reported as number of participants or number of 203 
events) were included in analyses, as reported. Too few studies reporting other 204 
anthropometric measures were found for the results to be combined for analysis. Analyses 205 
beyond the end of the intervention, that is, at longest follow-up, were not conducted 206 
because too few studies provided such results.  207 
Data, corrected to ensure comparable direction in the measures, were analysed as 208 
standardized mean difference (SMD) (Cohen’s d) with 95% confidence intervals (95%CI), 209 
using intention-to-treat (ITT) data (based on number of participants at study entry), where 210 
possible, or as Odds Ratios (Mantel-Haenszel estimations).35,36 Estimates were made using 211 
random effects models primarily, due to likely heterogeneity between studies. Fixed effect 212 
models were also applied as sensitivity analyses.35,36 Where research included multiple 213 
treatment or comparator groups, each treatment or comparator group was treated as an 214 
independent study, and numbers involved in single comparison groups were divided. 215 
Missing standard deviations (SDs) at end of intervention were carried forward from 216 




studies.37 For ΔBW for parallel groups studies, missing SDs were calculated from the results 218 
of simple linear regression analysis predicting SD from study duration (SI p 6).  219 
Heterogeneity between studies was investigated using Higgins’ I2 statistic.38,39 220 
Possible sources of heterogeneity were identified a-priori to include publication bias, and 221 
ROB. Possible publication bias was investigated using funnel plot asymmetry.40 Where 222 
sufficient data (≥ four studies) were available, the impact of ROB was assessed using 223 
sensitivity analyses which included only the studies judged to be low ROB as assessed using 224 
measures based on the use of ITT analyses and measures based on low (< 20%) drop out. 225 
These domains were selected as those considered most likely to influence study results. 226 
Exploratory analyses (meta-regression or subgroup analyses) were also conducted on LCS vs 227 
sugar parallel-groups studies to investigate the relationship between ΔBW and BWend and 228 
(1) duration of study, (2) sugar ‘dose' (i.e., difference in energy value of the sugar treatment 229 
minus LCS treatment), (3) whether participants were or were not blinded to their group 230 
allocation (LCS vs sugar), (4) whether LCS were provided in beverages or beverages and 231 
foods, and (5) funding source. Insufficient studies per subgroup were available for these 232 
exploratory analyses in cross-over studies, or studies investigating LCS vs water/nothing or 233 
LCS vs placebo.  234 
Analyses were undertaken in Stata (StataCorp LLC, Texas, USA).  235 
 236 
RESULTS 237 
Database searches were undertaken on 14th June, 2019 and updated on 2nd June 2020. A 238 
summary of the total number of records identified, through the selection of articles, to the 239 
number of studies included in the review is presented in Figure 1. Details of studies and data 240 
extracted are included in SI (Details of studies file). Results are presented per research 241 
question below. 242 
 243 
Figure 1 about here. 244 
 245 
(1) LCS vs sugar  246 
Included Studies. A total of 51 studies compared LCS with sugar: 37 parallel-groups studies21-247 
26,28-30,41-58 (one of these21 was partly reported earlier in59) and 14 cross-over studies60-68. 248 
Children were participants in 11 studies41,45,49,64, and adults were participants in 40 studies21-249 
24,26,28-30,42-44,46,50-63,65-68. In 13 studies, all the participants were people with overweight 250 
and/or obesity.21-24,26,28,29,52,53,60 Studies also included participants with type 1 diabetes63, 251 
type 2 diabetes44,61, or gall stones62. In two studies, the interventions were incorporated 252 
into an otherwise identical weight loss programme.24,26 Five articles reported research on 253 
exclusively female participants26,28-30,55, and one article reported research on exclusively 254 
male participants66. All other articles included both female and male participants (or gender 255 
was not specified46,47), with results reported separately for females and males in three 256 
articles54,58,65. In 33 studies the LCS vs sugar intervention involved beverages only21-24,28-257 
30,41,42-46,48,50,52,55-58,60,65,67,68, and in 18 studies it involved beverages and foods26,49,51,53,54,61-258 
64,66. The LCS was aspartame in 24 studies21-23,26,28-30,49,55-58,61,64,65, sucralose in six 259 
studies23,44,45,50,51, saccharin in four studies23,62,64, stevia/rebaudioside A in three 260 




specified24,42,43,46-48,52 in 13 studies. For the parallel-groups studies the median duration of 262 
the interventions was 12 weeks (1 to 78 weeks; mean = 16.5 weeks), and for the cross-over 263 
studies it was 3 weeks (1 to 6 weeks; mean = 3.2 weeks). Articles reporting 30 parallel-264 
groups studies21-24,26,28-30,41-43,45,46,50-53,55-58 and 13 cross-over studies60-62,64,65-67,68 provided 265 
data on sugar dose: parallel-group studies mean = 1272 kJ/d (median = 1308 kJ/d), cross-266 
over studies mean = 1542 kJ/d (median = 1591 kJ/d). The studies were carried out 267 
predominantly in the USA (28 studies) and Europe (16 studies).  268 
Assessments of ROB are summarised in SI Table 1a. Judgements of low ROB for use 269 
of ITT analysis were given to 22 studies23,24,28,41,49,53,60-64,66,68, and judgements of low ROB for 270 
low drop out were given to 34 studies24,28,30,42,43,45,48-53,57,58,60-64,66-68. For 35 studies, the 271 
authors report that participants were blinded to the intervention23,28-272 
30,41,44,45,49,53,55,57,58,60,61,64-67, although in three of these some participants correctly guessed 273 
their treatment allocation23,41,53. Twenty-two studies received funding from industry24,26,28,29, 274 
44,45,49,50,53,54,60,62,64, 21 did not21,23,30,41,42,43,51,52,57,61,65,67,68, and funding source was not 275 
reported for eight studies46,48,55,56,58,63,66.  276 
Meta-analyses (using random effects models) were conducted for ΔBW, BWend, 277 
ΔBMI, BMIend, EI and AE, with results subsequently converted to meaningful units. These 278 
results are summarised in Table 1. All original results (SMD, 95%CIs), together with results of 279 
all sensitivity analyses where missing SDs were imputed from means using fixed effects 280 
models and using only the studies of low risk of attrition bias (ITT analyses and drop out), 281 
are presented in SI Tables 2a-2d. 282 
 283 
Table 1 about here. 284 
 285 
BW and BMI. Twenty-nine LCS vs sugar studies using a parallel-groups design provided BW 286 
data that could be combined21-24,25,26,28-30,41,42,43,45,48,49,52,53,54,56,57, as did eight studies using a 287 
cross-over design60-63,66,68. Table 1 and Figure 2 show that for both types of study there was 288 
an effect on ΔBW in favour of LCS (i.e., consumption of LCS resulted in greater weight loss, 289 
or lower weight gain, than did consumption of sugar). Results for BWend show similar 290 
effects. The effects were smaller in the cross-over studies, and were not significant for 291 
BWend.  292 
Eleven studies using a parallel-groups design provided BMI data that could be 293 
combined21-23,41,45,48,52,53. They show an effect in favour of LCS for ΔBMI (Table 1 and Figure 294 
2). Two cross-over studies60,68 provided BMI data. Both found small, non-significant effects 295 
on BMI.  296 
There is moderate heterogeneity in the results for ΔBW and ΔBMI, and some funnel 297 
plot asymmetry (SI p 17). Effects are comparable, however, to those found in BWend and 298 
BMIend analyses. Furthermore, comparable but somewhat smaller effects were found in all 299 
sensitivity analyses. 300 
Six studies using a parallel-groups design44,46,47,50,55,58 provided only narrative BW 301 
data, and two parallel-groups design51 and two cross-over studies67 provided BW data only 302 
as medians and IQR. These studies reported no statistically significant differences in BW 303 
between LCS and sugar groups.   304 
 305 





Energy Intake. Twenty-two studies using a parallel groups design21-24,26,28-30,42,43,45,48,51-53,58, 308 
and 12 studies using a crossover design60,62,63,64-67 provided EI data that could be combined. 309 
In these studies EI was lower for LCS vs sugar (Figure 2). There is some heterogeneity, and 310 
some funnel plot asymmetry (SI p 17), but comparable effects were found in all sensitivity 311 
analyses.  312 
 313 
Adverse events. Eight studies provided data on adverse events.26,41-43,48,49 There was no 314 
difference in the occurrence of adverse events for LCS vs sugar (Table 1). 315 
 316 
Other anthropometric measures. Eleven studies provided data on other anthropometric 317 
measures: skinfold thickness41, waist-hip ratio ratio41, fat mass21-23,41,42,43,52, fat-free mass21-318 
23,52, waist circumference24,41,48,60 and hip circumference46. Results were similar in direction 319 
to the effects found in the analyses of BW and BMI data. 320 
 321 
(2) LCS vs water/nothing 322 
Included Studies: In the LCS vs water/nothing category, we included 21 studies: 17 parallel-323 
groups21,22,24,25,27,42,43,46-48,55,69-75 and four cross-over studies,65,76,77. All studies were 324 
conducted with solely adult participants. In seven studies, all the participants were people 325 
with overweight and/or obesity22,24,25,27,69,70,73, and in two studies, the participants were 326 
people with type 2 diabetes70 or pre-diabetes76. In seven studies, the interventions were 327 
incorporated into an otherwise identical weight loss programme24,25,27,69,70,73,76. Three 328 
articles reported research on solely female participants27,55,70, for one study the gender of 329 
participants was not reported71, while all other articles included both female and male 330 
participants, with results reported separately for females and males in three articles65,73,75. 331 
The intervention involved consumption of LCS beverages ranging from 250 ml/d 5 days per 332 
week27,70 to 1.2 L/d61. Eighteen studies involved the consumption of LCS in 333 
beverages21,22,24,25,27,42,43,48,55,65,69-72,74,75,77, two studies included consumption of both LCS-334 
sweetened beverages and foods73, while in another study participants sucked two tablets 335 
containing aspartame before meals76. In 14 studies water, either still and/or carbonated, or 336 
unsweetened beverages were the comparators21,2224,27,42,43,46,48,55,69,70,74,76,77, and in 7 studies 337 
‘nothing’ was the comparator (i.e., the comparator was the omission of the LCS 338 
treatment65,71,72,73,76). The LCS was aspartame in eight studies21,22,55,65,72,73,76, sucralose in 339 
two studies74, aspartame and acesulfame-K in one study77, acesulfame-K, aspartame and 340 
sucralose in one study75, stevia in one study71, and was not specified for the other 341 
studies24,27,42,43,46,48,69,70. The minimum duration of the interventions was 3 weeks65 and the 342 
maximum was 77 weeks27 (median duration = 12 weeks). The studies were carried out 343 
predominantly in the USA (10 studies) and Europe (five studies).  344 
Assessments of ROB are summarised in SI Table S1b. Judgements of low ROB for use 345 
of ITT analyses were given to six studies24,70,71,75,76, and judgements of low ROB for low drop 346 
out were given to 13 studies24,27,42,43,48,70-73,75-77. For ten studies24,27,42,43,48,65,70,74,77 the 347 
authors report that the researchers and/or analysts were blinded to the intervention 348 
allocated to respective participants. Blinding was not possible for participants due to the 349 
nature of the intervention. There was no researcher/analyst blinding in one study21, and 350 
blinding was not reported for the other studies46,55,69,71,72,73,76. Eight studies received funding 351 
from industry24,69,72,73,75,77, nine did not21,27,42,43,65,70,71,74, and funding source was not 352 





BW and BMI. Eleven parallel-groups studies that compared LCS with water/nothing 355 
provided BW data that could be combined21,22,24,27,42,43,48,69-73, as did four studies using a 356 
cross-over design65,76,77. Eight parallel-groups studies21,22,27,48,70,73,74, but no cross-over 357 
studies, provided data for BMI that could be combined. Analyses showed no effect of LCS vs 358 
water/nothing for BW or BMI (Table 1 and Figure 3). These analyses also revealed 359 
considerable heterogeneity in results, and some funnel plot asymmetry (SI p 18). Some 360 
different effects were found in the sensitivity analyses using fixed effect models, possibly 361 
due to differing effects in larger studies24,69, and in sensitivity analyses for ROB where these 362 
could be conducted (SI Tables 2a-2d). Three studies provided data that could not be 363 
analysed.46,55,75 The authors of these studies report no effect of LCS vs water on body 364 
weight.  365 
 366 
Energy Intake. Ten parallel-groups studies21,24,25,27,42,43,48,70,74,75 and three cross-over 367 
studies65,77 provided EI data that could be combined. Analyses showed higher EI for LCS in 368 
parallel-groups studies, but lower EI for LCS in cross-over studies (Table 1). Within these two 369 
sets of studies there is low heterogeneity in results, and some funnel plot asymmetry (SI p 370 
18). Similar effects were found in all sensitivity analyses that could be conducted (SI Tables 371 
2a-2d).   372 
 373 
Adverse events. Results for adverse events were reported for four studies.43,48,74 In total, 374 
thirteen adverse events were recorded for the LCS groups, mainly in two studies74, while 375 
zero adverse events were recorded for the water/nothing treatment groups. 376 
 377 
Other anthropometric measures: Eight studies provided data on other anthropometric 378 
measures: fat mass21,22,42,43,72, fat-free mass21,22,72, waist circumference24,27,48,69,70,77 hip 379 
circumference48. Results for these measures do not differ clearly from the pattern of results 380 
for BW and BMI. 381 
 382 
Figure 3 about here 383 
 384 
(3) LCS capsules vs placebo capsules 385 
Included Studies. Of the 16 included capsule studies, 15 used a parallel-groups design72,78-89 386 
and one a cross-over design90. All studies, except one89 (males only), included both male and 387 
female participants, with type 2 (non-insulin-dependent) diabetes82,84,86, hypertension78-80, 388 
type 1 diabetes84, chronic kidney disease83, hyperlipidemia87, or participants who were 389 
healthy72,81,84,88-90, including some individuals with overweight/obesity85. One study85 390 
included participants aged 10 to 21 y. All other studies were conducted with solely adult 391 
participants. The capsulated LCS was stevia/rebaudioside A (10 studies78-80,82-84,87,88, 200 392 
mg/d to 1.5 g/day), aspartame (four studies72,81,85,86, 700 mg/d to 5 g/d), or sucralose (two 393 
studies89,90, 200 and 780 mg/d). The comparators were placebo capsules. The minimum 394 
duration of the interventions was 7 days89 and the maximum was 2 years78 (median 395 
duration = 13 weeks).  396 
Assessments of ROB are summarised in SI Table 1c. All articles reported that the 397 
studies were carried out double blind, except for one single-blind study.83 Three studies 398 




drop out. The studies were carried out in the USA (six studies), South America (six studies) 400 
and Asia (four studies). Five studies received funding from industry72,81,82,85,88, eight did 401 
not80,83,84,87,89,90. Funding source was not reported for three studies78,79,86.  402 
 403 
BW and BMI. Seven studies provided data for BW that could be combined72,81-83,85,86,89, and 404 
eight (predominantly different) studies provided data for BMI that could be 405 
combined78,79,80,83,84,87. Taken together, results of the analyses show no effect of LCS 406 
capsules vs placebo capsules for BW or BMI (Table 1 and Figure 4). A small effect was found 407 
in favour of placebo for ΔBMI, but limited original SD data were available to conduct this 408 
analysis. Heterogeneity for these results is low, and funnel plot asymmetry is low (SI p 19). 409 
Comparable effects were found using fixed effect models. In all studies drop out was 410 
reported to be low, but ITT analysis was reported for only a minority of studies. Two studies 411 
provided narrative results on BW.88,90 The authors of these studies reported no effect of LCS 412 
vs placebo. 413 
 414 
Energy Intake. Narrative results on EI were provided for two studies88,90. The authors of 415 
these studies report no effect of LCS vs placebo. 416 
 417 
Adverse events. Thirteen studies provided data on adverse events78-82,84-89 There was no 418 
difference in the occurrence of adverse events for LCS vs placebo (Table 1). Heterogeneity 419 
for these results is low, but there is considerable funnel plot asymmetry. Similar effects 420 
were found in the sensitivity analyses based on ROB (SI Tables 2a-2d).  421 
 422 
Figure 4 about here 423 
 424 
Exploratory Analyses 425 
The analyses below are for LCS vs sugar parallel-groups studies (random effects models). 426 
 427 
Duration of study. Results of meta-regression analyses show no association between 428 
duration (weeks) of intervention and ΔBW (29 studies) or BWend (26 studies): largest 429 
coefficient = 0.005 (-0.002, 0.011), P = 0.15). 430 
 431 
Sugar dose. Results of meta-regression analyses show an association between sugar dose 432 
replaced by LCS (MJ) and ΔBW: 22 studies, coefficient = -0.344 (-0.535, -0.152), P < 0.01. 433 
Results show a smaller effect for BWend: coefficient = -0.126 (-0.263, 0.010), P = 0.07. The 434 
magnitude of this effect is such that for every 1 MJ of energy replaced by LCS, ΔBW 435 
decreases by 0.344 SDs or approximately 1.06 kg in adults assuming a mean ΔBW SD of 3.07 436 
kg. 437 
 438 
Blinding. Twenty-six studies provided information on whether participants were or were not 439 
blinded to the intervention. Results of subgroup analyses show no difference in the effect of 440 
the intervention as a function of blinding for either ΔBW or BWend (participants categorised 441 
as blinded, not blinded and unintentionally not blinded: largest χ2(2) = 1.59, P = 0.45).  442 
 443 
LCS provision in beverages or in foods and beverages. Twenty-nine studies provided data on 444 
LCS provision. Subgroup analyses for ΔBW and BWend show no differences between the 445 





Funding source. Twenty-five studies provided information on funding source. Subgroup 448 
analyses show no differences between industry-funded and non-industry-funded studies in 449 
the effect of the intervention on ΔBW and BWend (largest: χ2(1) = 0.02, P = 0.89).   450 
 451 
Excluded studies 452 
Five articles49,50,54,56,67 that reported studies that we analysed also reported other studies 453 
that did not meet our inclusion criteria. In two cases49,54 this was because participants in the 454 
intervention group consumed LCS in foods/beverages and in capsules, while the comparator 455 
group consumed neither.  456 
 457 
DISCUSSION 458 
This review and meta-analyses sought to address three questions concerning the potential 459 
effects of LCS on BW, BMI and EI: (1) the effects of LCS compared with sugar (i.e., when 460 
there is a difference in energy content of the target beverages and/or foods consumed, 461 
while taste is controlled); (2) the effects of LCS compared with water or nothing (i.e., where 462 
there is no meaningful difference in energy content between treatments, while there is a 463 
difference in taste); and (3) the effects of LCS consumed in capsules vs placebo capsules 464 
(i.e., where there is no meaningful difference in energy content between treatments, and 465 
no difference in taste).  466 
Our searches identified a considerable number of studies overall, and sufficient 467 
studies to answer each of the three questions. Almost all studies relevant to the first two 468 
questions were designed deliberately to test effects of LCS on BW, BMI and/or EI, in real life 469 
settings. A majority manipulated LCS consumption solely via beverages. A large majority of 470 
all studies was conducted with adult participants, and included individuals with healthy 471 
weight, overweight and/or obesity, and/or health conditions such as diabetes. In some 472 
studies, the intervention was superimposed on a weight loss programme.  473 
 474 
LCS vs sugar 475 
Consistent with the primary intended use of LCS, the results for both parallel-groups and 476 
cross-over studies showed that BW, BMI and EI were reduced by consumption of LCS 477 
compared with sugar. More limited data showed no difference in occurrence of adverse 478 
events between the LCS and sugar interventions.  479 
The magnitude of effects in favour of LCS, for example, 1.06 kg for ΔBW in the 480 
parallel-groups studies, might be regarded as modest, nonetheless theoretically the effects 481 
on BW should be influenced by the energy difference between the LCS and sugar 482 
interventions (i.e., sugar dose) and the duration of the intervention. For the parallel-groups 483 
studies mean sugar dose was 1272 kJ/d and median intervention duration was 12 weeks. 484 
The results of our exploratory analyses support an effect of sugar dose. This effect of sugar 485 
dose is consistent with reduced EI being the primary means by which LCS reduces BW. For 486 
the parallel-groups studies in which it was measured, the mean difference in EI was 941 kJ/d 487 
(Table 1). Plausibly, the 26% difference in sugar dose and measured difference in EI is 488 
explained by increased EI from the rest of the diet which partially, but not fully, 489 




beverages.10,17,91 The absence of an effect of duration of these studies may in part reflect 491 
diminishing adherence to interventions over time, and to a lower intensity (including lower 492 
sugar dose) of the intervention in longer-duration studies. Nevertheless, difference in BW in 493 
favour of LCS (-0.53 kg for ΔBW) was smaller for the shorter duration cross-over studies 494 
(median duration 3 weeks).  495 
A further result was that there was no difference in the effect on BW between 496 
studies in which participants were blinded vs not blinded to their allocation to LCS or sugar. 497 
This is consistent with other evidence for a lack of ‘conscious EI compensation’ with 498 
consumption of LCS foods and/or drinks.8 It is also worth noting that, in common with all 499 
weight management interventions, the long term effect of consuming LCS in place of (some) 500 
sugar in the diet will be further limited by the increase in appetite and decrease in energy 501 
expenditure that occurs with weight loss.17,92,93  502 
Difference in results across studies (heterogeneity) was mostly low to moderate. In 503 
addition to sugar dose, study duration and participant blinding, other analyses of potential 504 
sources of heterogeneity revealed no effects of consumption of LCS in beverages vs 505 
beverages and foods, or funding source (industry vs non-industry funding).  506 
Sensitivity analyses using fixed effect models suggested low bias due to the inclusion 507 
of some large studies, but funnel plots provided evidence of biases associated with study 508 
size, including possible publication bias. Sensitivity analyses using only the studies judged to 509 
be low in attrition bias also suggest some impact of attrition. In this respect, the effects of 510 
LCS on BW and EI were smaller when only studies with low drop out were considered. These 511 
findings perhaps indicate an effect related to the acceptability or other aspects of the 512 
intervention.  513 
 514 
LCS vs water or nothing 515 
Overall, there was no effect of LCS vs water/nothing on BW or BMI. Results for parallel-516 
groups studies showed higher EI with LCS than with water/nothing, but the cross-over 517 
studies showed an effect in the opposite direction. Furthermore, there was inconsistency in 518 
results (considerable heterogeneity) for effects on ΔBW and ΔBMI within the parallel-groups 519 
studies. Taken together, these results are consistent with the zero difference in energy 520 
content of the LCS and comparator treatments in these studies, and with a lack of effect of 521 
dietary exposure to sweetness on intake of sweet foods and beverages observed in other 522 
studies.9 523 
The explanation for large differences in results between studies comparing LCS vs 524 
water is uncertain. There was some evidence for biases associated with study effect size, 525 
such as publication bias. Furthermore, relatively few studies were available, and they varied 526 
widely in procedural details. The study69 of this type with the largest number of participants 527 
enrolled consumers of LCS beverages to a behavioural weight loss programme which 528 
included randomisation to continue to consume LCS beverages or water. It found an effect 529 
on BW in favour of LCS. In contrast, two studies27,70, also involving a weight loss programme, 530 
in which participants were permitted to consume one LCS beverage after lunch 5 d per 531 
week, showed an effect on BW, and on EI, in favour of water over LCS. It is unknown why 532 





LCS in capsules vs placebo 535 
Taken together, the results from these studies show no effect of LCS consumed in capsules 536 
compared to the consumption of (presumably inert) placebo capsules. This indicates that, 537 
beyond the effect due to reduced sugar intake, there is no meaningful post-ingestive effect 538 
on overall energy balance of the LCS tested, namely aspartame, stevia and sucralose.  539 
For BW and for BMI, differences in results across studies (heterogeneity) was low. 540 
Across measures, however, results were inconsistent. For ΔBMI there was a statistically 541 
significant effect in favour of placebo, whereas the pattern of effects for ΔBW change, 542 
BWend and BMIend was, if anything, in favour of LCS. What accounts for these different 543 
results is unclear. Relatively few studies were available, and they largely reported BW or 544 
BMI, so the different outcomes may reflect different study procedures or differences in 545 
effects of different LCS. Stevia was the LCS in all the studies78-80,83,84,87 reporting BMI as an 546 
outcome, whereas aspartame was the LCS in four72,81,85,86 of the seven studies reporting BW 547 
as an outcome. However, BW was also measured in two stevia studies82,83 both of which 548 
showed small effects (non-significant) for ΔBW favouring stevia over placebo. Two studies 549 
found no effects of sucralose vs placebo on BW89,90, and one no effect on EI90. Therefore, in 550 
relation to energy balance, the available studies provide information about the (lack of) 551 
post-ingestive effects of three LCS. Notably, there was no difference in occurrence of 552 
adverse events between the LCS and placebo interventions, even in studies in which 553 
unusually high doses of LCS were consumed.78,85,86 554 
While there is great diversity in the molecular structure of different LCS16, currently 555 
there is limited evidence on whether different LCS differ in their effects on energy 556 
balance16,23. Their common feature is that they provide sweetness with zero or essentially 557 
zero energy, which is likely to be the primary reason why they reduce EI, BW and BMI 558 
compared with sugar. Further capsule studies on a wider range of LCS, and further studies 559 
like that of Higgins and Mattes23 comparing the effects of different LCS (or even different 560 
combinations of LCS) vs sugar, would be informative, but a large undertaking.  561 
 562 
Comparison with other reviews 563 
Five systematic reviews with meta-analyses of the effects of LCS on BW have been published 564 
previously.10-13,94 The most recent of these reviews94 included fewer studies overall than the 565 
present review, and it did not investigate effects on EI. It also included two studies31,32 that 566 
we excluded on the grounds that the LCS intervention was confounded with other strategies 567 
for reducing sugar-sweetened beverage intake.  568 
In agreement with the results of the present review, three of the previous reviews 569 
found clear evidence that consumption of LCS reduces BW compared with the consumption 570 
of sugar10,11,94. The other two12,13, however, are equivocal about the effect of LCS 571 
consumption on BW; for example, “Evidence from RCTs does not clearly support the 572 
intended benefits of nonnutritive sweeteners for weight management” (p E93712). On the 573 
face of it these different conclusions are puzzling, especially as these two reviews are 574 
relatively recent and so had access to most of the studies we have included here. 575 
Furthermore, all these reviews include some of the same studies included in other reviews 576 




 Closer examination reveals important differences in the numbers of studies included 578 
in each of the reviews, and/or how studies are grouped for analysis. For example, Toews et 579 
al.13 included only five studies in their meta-analysis of effects of LCS on BW. Among their 580 
criteria for inclusion of studies was that LCS “type was sufficiently specified”, but arguably 581 
this is unnecessarily restrictive. It led, for example, to the exclusion of a large study 582 
(n=210)24 in which participants were provided with “any combination of noncaloric 583 
sweetened beverages of their choice” (p 55624), so various types of LCS would have been 584 
consumed. Critically, however, in relation to potential effects on BW, what the beverages in 585 
this study had in common was sweetness and zero sugar and energy content. In contrast, 586 
the largest study (n = 100) included by Toews et al.13 in their BW meta-analysis, compared 587 
the effect of LCS capsules vs placebo capsules.88 This comparison is not relevant to the 588 
intended use of LCS as a replacement for sugar in foods and beverages. The inappropriate 589 
inclusion of this study with its null effect had a substantial effect on the overall result. As 590 
discussed by other authors96, similar issues of the selection and combination of studies are 591 
present in the review by Azad et al.12 To arrive at valid conclusions about the effects of LCS 592 
consumption on BW it is necessary to frame research questions and hypotheses in terms of 593 
plausible biological and behavioural mechanisms.14 This is the approach we have taken here.   594 
 595 
Limitations 596 
While there were a substantial number of LCS vs sugar studies, our review is limited by the 597 
relatively smaller number of studies available to address our second and third research 598 
questions. Our funnel plots show asymmetry, suggesting possible publication bias within the 599 
set of studies included and the reduced effects in the analyses of studies with low attrition 600 
bias indicate the presence of other biases. Many studies also failed to report SDs for ΔBW or 601 
ΔBMI, thus requiring imputation, and none of the cross-over studies reported the 602 
correlation between data for the different intervention arms, requiring estimations in our 603 
analyses of cross-over studies. Our searches were confined to articles published in English. 604 
We did, however, allow the inclusion of conference abstracts and trial registrations, 605 
resulting in the inclusion of some studies that have not been included in other similar 606 
reviews.  607 
 608 
Conclusions and future directions 609 
The results of this review show that consumption of LCS vs sugar decreases BW, and that it 610 
does so via decreasing daily EI. The studies available to test these effects included adults 611 
and children, with healthy weight, overweight and obesity, and consumption of LCS or sugar 612 
in beverages, or in beverages and foods. In contrast, there was no clear evidence of effects 613 
on BW or EI of LCS compared with the consumption of water/nothing. There were, however, 614 
substantial differences in results across studies, so further research on this question would 615 
be valuable. At least one such study is in progress.97 Relatedly, further studies that 616 
randomise high consumers of sugar-sweetened beverages to LCS beverages, water, or no 617 
change in beverage consumption will strengthen the evidence base for recommendations 618 
for this group of consumers. There was also no evidence overall of an effect of LCS 619 




sugar intake, there is no meaningful post-ingestive effect of LCS on energy balance. 621 
Occurrence of adverse events did not differ between LCS and comparator interventions. 622 
 623 
Supplementary information is available at International Journal of Obesity’s website. 624 
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Table 1. Summary of the results of the meta-analyses (random effects models), estimates converted to relevant units 
 
Outcome Parallel groups studies  Cross-over studies 
Na Nb SMD estimates converted 
to relevant unitsc 
I2 d  Na Nb SMD estimates converted 
to relevant units, c 
I2 d 
LCS vs sugar  
ΔBW, kge 29 2267 -1.06 (-1.50, -0.62)** 51  8 123 -0.53 (-1.01, -0.05)* 0 
BWend, kg  26 2196 -1.45 (-2.50, -0.41)* 0  8 123 -0.55 (-5.34, 4.25) 0 
ΔBMI, kg/m2 11 1348 -0.35 (-0.58, -0.12)** 70  2    
BMIend, kg/m2 11 1348 -0.27 (-0.63, 0.10) 0  2    
Energy intake, kJ 22 1397 -941 (-1341, -541)** 45  12 149 -1304 (-2118, -489)** 0 
Adverse events (OR) 8 1064 0.99 (0.64, 1.53) 0  0    
LCS vs water/nothing  
ΔBW, kge 11 1068 0.10 (-0.87, 1.07) 82  4 134 -0.45 (-0.91, 0.00)* 0 
BWend, kg  10 1040 -0.01 (-1.55, 1.53) 3  4 134 -0.05 (-0.50, 0.39) 0 
ΔBMI, kg/m2 8 431 0.20 (-0.10, 0.51) 64  0    
BMIend, kg/m2 8 431 0.23 (-0.40, 0.87) 0  0    
Energy intake, kJ 9 756 676 (267, 1085)** 19  3 80 -431 (-1711, 850)* 0 
Adverse events (OR) 3     2    
LCS capsules vs placebo capsules  
ΔBW, kge 7 521 -0.28 (-0.80, 0.25) 0  0    
BWend, kg  7 521 -0.82 (-2.94, 1.30) 0  0    
ΔBMI, kg/m2 8 486 0.20 (0.04, 0.36)* 0  0    
BMIend, kg/m2 8 486 -0.47 (-1.07, 0.13) 0  0    
Energy intake, kJ 0     0    
Adverse events (OR) 10 786 0.83 (0.64, 1.07) 0  0    
Abbreviations: LCS, low-calorie sweeteners; ΔBW, change in body weight; BWend, body weight at the end of the intervention; ΔBMI, change in body mass index; 
BMIend, body mass index at the end of the intervention; OR, odds ratio. aNumber of studies providing data suitable for analysis and included in the analysis. 
bNumber of participants in the analysis. cStandardised mean difference and (95% CIs), converted to relevant units; a minus sign shows an effect in favour of LCS. 
dMeasure of differences in results between studies (heterogeneity, %). eFor parallel-groups studies simple linear regression with study duration as the predictor 
variable was used to estimate missing SDs. For cross-over studies and all other variables, missing SDs were imputed using mean SD. **P ≤ .01, *P < .05. Results are 
for energy intake and adverse events measured during the intervention. Where cells are empty no analyses were undertaken due to insufficient numbers of 































Figure 2. Forest plots showing individual and overall standardised mean differences (SMD) for the effects of LCS vs sugar for ΔBW and EI measured in parallel-
groups studies (random effects models). Diamonds represent SMDs, square size represents the weight of the study (% contribution of the study to the overall 
result) and the horizontal lines represent the 95%CIs. Studies are ordered by duration of study (longest first), then date of completion (most recent first). Results 
to the left of the 0 line are in favour of LCS and results to the right of the line are in favour of sugar. For ΔBW the overall result can be converted to -1.06 (-1.50, -
0.62) kg, and for EI the overall result can be converted to -941 (-1341, -541) kJ/d. Numbers in parentheses are study article reference numbers. Participants in 
studies (41), (45) and (49) were children. All other studies were conducted solely with adult participants. 

















Figure 3. Forest plots showing individual and overall standardised mean differences (SMD) for the effects of LCS vs water/nothing for ΔBW and EI measured in 
parallel-groups studies (random effects models). Diamonds represent SMDs, square size represents the weight of the study (% contribution of the study to the 
overall result) and the horizontal lines represent the 95%CIs. Studies are ordered by duration of study (longest first), then date of completion (most recent first). 
Results to the left of the 0 line are in favour of LCS and results to the right of the line are in favour of sugar. For ΔBW the overall result can be converted to 0.10 (-
0.87, 1.07) kg, and for EI the overall result can be converted to 676 (267, 1085) kJ/d. Numbers in parentheses are study article reference numbers. 
  





















Figure 4. Forest plots showing individual and overall standardised mean differences (SMD) for the effects of LCS capsules vs placebo capsules for ΔBW and ΔBMI 
measured in parallel-groups studies (random effects models). Diamonds represent SMDs, square size represents the weight of the study (% contribution of the 
study to the overall result) and the horizontal lines represent the 95%CIs. Studies are ordered by duration of study (longest first), then date of completion (most 
recent first). Results to the left of the 0 line are in favour of LCS and results to the right of the line are in favour of sugar. For ΔBW the overall result can be 
converted to -0.28 (-0.80, 0.25) kg, and for ΔBMI the overall result can be converted to 0.20 (0.04, 0.36) kg/m2. Numbers in parentheses are study article reference 
numbers. Participants in study (85) were aged 10-21 years. All other studies were conducted solely with adult participants. 
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